title: Fucoidan inhibits leukocyte recruitment in a model peritoneal inflammation in rat and blocks interaction of P-selectin with its carbohydrate ligand.
abstract: Neutrophil recruitment into systemic inflammatory sites in vivo is thought to be initiated by selectin-mediated endothelial adherence. The effect of fucoidan (natural sulfated polymer of L-fucose) on the selectin dependent PMN migration into rat peritoneum following the induction of inflammation by peptone injection was studied. Peritonitis was characterized by an increase in the total cell number (from 45.3 x 10(6) to 91.6 x 10(6)/rat), and by highly elevated PMN content (from 0.2% to 58%) in the rat peritoneal cavity 3 h after peptone injection. Intravenous administration of fucoidan was found to reduce, in a dose-dependent manner, neutrophil migration into peritoneum. Fucoidan in a dose as low as 0.8 mg per rat caused 96.8% reduction of neutrophil extravasation. The inhibitory effect of fucoidan was also dependent on the time intervals between the peptone and fucoidan injections. The maximal inhibitory effect of fucoidan was observed within the first 15 min after the induction of peritonitis and it was maintained at a level of 80% during 1.5 h. Administration of fucoidan 2.5 h after peptone injection had practically no effect on PMN extravasation. Since P-selectin is known to play a key role at the earlier stages of PMN extravasation, it was suggested that the inhibitory effect of fucoidan was mostly due to its interaction with P-selectin. The in vitro experiments demonstrated the high affinity of fucoidan for both isolated P-selectin and P-selectin in plasma membranes of activated platelets.
authors.affiliation: Institute of Biomedical Chemistry, Russian Academy of Medical Sciences, Pogodinskaya, Moscow.
authors.forename: M E
authors.initials: ME
authors.lastname: Preobrazhenskaya
authors.forename: A E
authors.initials: AE
authors.lastname: Berman
authors.forename: V I
authors.initials: VI
authors.lastname: Mikhailov
authors.forename: N A
authors.initials: NA
authors.lastname: Ushakova
authors.forename: A V
authors.initials: AV
authors.lastname: Mazurov
authors.forename: A V
authors.initials: AV
authors.lastname: Semenov
authors.forename: A I
authors.initials: AI
authors.lastname: Usov
authors.forename: N E
authors.initials: NE
authors.lastname: Nifant'ev
authors.forename: N V
authors.initials: NV
authors.lastname: Bovin
mesh_terms: D000818:Animals; D019921:Biotinylation; D001792:Blood Platelets / Q000378:metabolism; D018395:CA-19-9 Antigen; D050260:Carbohydrate Metabolism; D002465:Cell Movement; D005260:Female; D005732:Gangliosides / Q000378:metabolism; D006801:Humans; D007700:Kinetics; D009504:Neutrophils / Q000187:drug effects* / Q000502:physiology; D009844:Oligosaccharides / Q000378:metabolism; D019007:P-Selectin / Q000378:metabolism*; D010461:Peptones; D010538:Peritonitis / Q000139:chemically induced / Q000473:pathology*; D011134:Polysaccharides / Q000494:pharmacology*; D051381:Rats; D017208:Rats, Wistar; D000080506:Sialyl Lewis X Antigen
chemical_list: D018395:CA-19-9 Antigen; D005732:Gangliosides; D009844:Oligosaccharides; D019007:P-Selectin; D010461:Peptones; D011134:Polysaccharides; D000080506:Sialyl Lewis X Antigen; C007789:fucoidan; C064564:sialyl Le(a) ganglioside